Volume 1, Issue 2 , Pages 122-127, April 2008
Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: A replication study
To access this article, please choose from the options below
The work was supported by funding from the National Institute for Neurological Disorders and Stroke at the National Institutes of Health (NIH), Cyberonics Inc, and the Neurosciences Institute at MUSC (JJB); the National Institute for Mental Health, NIDA, and NIAAA at NIH, Jazz Pharmaceuticals, GlaxoSmithKline, and Cyberonics Inc (MSG); the National Institute for Mental Health at NIH, and Cyberonics In (ZN); and the National Institute for Mental Health at NIH and the US Department of Defense (AK).
MUSC has filed 6 patents or invention disclosures in one or more of the authors' names regarding brain imaging and stimulation.
Dr. George is a consultant for Aspect Biomedical, Argolyn, Aventis, Abbott, Bristol-Meyers Squibb, Cephos, Cyberonics, and Neuropace; however, he has no equity ownership in any device or pharmaceutical company.
Dr. Nahas is a consultant for Neuropace.
The views expressed herein are those of the authors and do not necessarily reflect the views of the National Institutes of Health or the US Department of Defense.
PII: S1935-861X(08)00013-2
doi:10.1016/j.brs.2008.04.002
© 2008 Elsevier Inc. All rights reserved.
Volume 1, Issue 2 , Pages 122-127, April 2008
